A young boy with elevated aminotransferases in physical examination--Two novel missense mutations associated with Wilson's disease were found.
- Author:
Yu ZHU
1
;
Si-Yan DENG
;
Chao-Min WAN
Author Information
1. Department of Pediatrics, West China Second Hospital of Sichuan University, Chengdu 610041, China. wcm0220@126.com.
- Publication Type:Case Reports
- MeSH:
Adenosine Triphosphatases;
genetics;
Alanine Transaminase;
blood;
Cation Transport Proteins;
genetics;
Child, Preschool;
Copper-transporting ATPases;
Female;
Hepatolenticular Degeneration;
genetics;
physiopathology;
Humans;
Liver;
physiopathology;
Male;
Mutation, Missense;
Physical Examination
- From:
Chinese Journal of Contemporary Pediatrics
2015;17(7):741-743
- CountryChina
- Language:Chinese
-
Abstract:
A 3-year-old boy had abnormal liver function, which was found in physical examination, for 5 months before admission. He had no symptoms such as anorexia, poor appetite, and jaundice, had normal growth and development, and showed no hepatosplenomegaly. Laboratory examination revealed significantly reduced ceruloplasmin (35 mg/L), as well as negative hepatotropic virus, cytomegalovirus, and Epstein-Barr virus. There were normal muscle enzymes, blood glucose, and blood ammonia and negative liver-specific autoantibodies. The boy had negative K-F ring and normal 24-hour urine copper (0.56 μmol/L). The ATP7B gene testing for the boy, his sister, and their parents detected two novel missense mutations in the boy and his sister, i.e., compound heterozygous mutations in exon 7 (c.2075T>C, p.L692P) and exon 13 (c.3044T>C, p.L1015P), which were inherited from their father and mother, respectively. Wilson's disease was confirmed by genetic diagnosis in the boy and his sister. The boy and his sister were given a low-copper diet. The boy was administered with penicillamine for decoppering and zinc supplement against copper uptake. His sister received zinc supplement alone because no clinical symptoms were observed. The boy showed normal liver function in the reexamination after 3 months of treatment.
